You are here

Research

Problem: Unapproved stem-cell therapies are being marketed to people with long COVID

New research has identified 38 direct-to-consumer businesses marketing stem-cell treatments and exosome therapies for COVID-19 infections and, especially, long COVID, despite lacking approval by US Food and Drug Administration and other regulatory body in the United States. Descriptions of the businesses and an analysis of their marketing strategies are published in Stem Cell Reports.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

US, global COVID-19 indicators show declines

COVID-19 activity in the United States last week showed more signs of declines, though deaths were up, and the World Health Organization's (WHO's) monthly snapshot of global activity suggests decreased activity, though the group cautioned that few countries are reporting data.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pfizer’s says its combination Covid, flu vaccine will move to final-stage trial after positive data

Pfizer combination Covid, flu vaccine shows positive trial data (cnbc.com)

 

  • Pfizer said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results. ..
  • Pfizer and other vaccine makers like Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against respiratory viruses that typically surge around the same time of the year.
  • ...

 

       

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks